Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful Pain Management with Epidural Oxytocin.

Literature DB >> 27080720

Successful Pain Management with Epidural Oxytocin.

Miguel Condés-Lara¹, Héctor Zayas-González^1,2, Alfredo Manzano-García¹, Estefanía Córdova-Quiroz², Juan Granados-Mortera², Marco García-Cuevas², Julio Morales-Gómez², Abimael González-Hernández¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2016 PMID： 27080720 PMCID： PMC6492780 DOI： 10.1111/cns.12551

Source DB: PubMed Journal: CNS Neurosci Ther ISSN： 1755-5930 Impact factor: 5.243

× No keyword cloud information.

10 in total

1. Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist.

Authors: Yuritzia Miranda-Cardenas; Gerardo Rojas-Piloni; Guadalupe Martínez-Lorenzana; Javier Rodríguez-Jiménez; Mónica López-Hidalgo; Marie José Freund-Mercier; Miguel Condés-Lara
Journal: Pain Date: 2006-03-09 Impact factor: 6.961

2. PVN electrical stimulation prolongs withdrawal latencies and releases oxytocin in cerebrospinal fluid, plasma, and spinal cord tissue in intact and neuropathic rats.

Authors: Guadalupe Martínez-Lorenzana; Lizbeth Espinosa-López; Martha Carranza; Carlos Aramburo; Carlos Paz-Tres; Gerardo Rojas-Piloni; Miguel Condés-Lara
Journal: Pain Date: 2008-09-26 Impact factor: 6.961

3. Distribution and identity of neurons expressing the oxytocin receptor in the mouse spinal cord.

Authors: Ludovic Wrobel; Ara Schorscher-Petcu; Anouk Dupré; Masahide Yoshida; Katsuhiko Nishimori; Eliane Tribollet
Journal: Neurosci Lett Date: 2011-03-23 Impact factor: 3.046

4. Oxytocin and analgesia: future trends.

Authors: Abimael González-Hernández; Gerardo Rojas-Piloni; Miguel Condés-Lara
Journal: Trends Pharmacol Sci Date: 2014-09-27 Impact factor: 14.819

Review 5. Oxytocin and pain: a systematic review and synthesis of findings.

Authors: Joshua A Rash; Aldo Aguirre-Camacho; Tavis S Campbell
Journal: Clin J Pain Date: 2014-05 Impact factor: 3.442

6. Intranasal Oxytocin Administration is Associated With Enhanced Endogenous Pain Inhibition and Reduced Negative Mood States.

Authors: Burel R Goodin; Austen J B Anderson; Emily L Freeman; Hailey W Bulls; Meredith T Robbins; Timothy J Ness
Journal: Clin J Pain Date: 2015-09 Impact factor: 3.442

7. Distribution of vasopressin and oxytocin binding sites in the brain and upper spinal cord of the common marmoset.

Authors: Ara Schorscher-Petcu; Anouk Dupré; Eliane Tribollet
Journal: Neurosci Lett Date: 2009-06-17 Impact factor: 3.046

8. Preclinical toxicity screening of intrathecal oxytocin in rats and dogs.

Authors: Tony L Yaksh; Shotaro Hobo; Christopher Peters; Kent G Osborn; Philip J Richter; Steven S Rossi; Marjorie R Grafe; James C Eisenach
Journal: Anesthesiology Date: 2014-04 Impact factor: 7.892

9. Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain.

Authors: I Madrazo; R E Franco-Bourland; V M León-Meza; I Mena
Journal: Appl Neurophysiol Date: 1987

10. Phase 1 safety assessment of intrathecal oxytocin.

Authors: James C Eisenach; Chuanyao Tong; Regina Curry
Journal: Anesthesiology Date: 2015-02 Impact factor: 8.986